Context matters: the evolving use of biomarkers in Alzheimer's disease care by Juan Fortea

Get full text

Sex-related differences in genetically determined Alzheimer’s disease by Laura Del Hoyo Soriano, Laura Del Hoyo Soriano, Olivia Wagemann, Alexandre Bejanin, Alexandre Bejanin, Johannes Levin, Johannes Levin, Johannes Levin, Juan Fortea, Juan Fortea, Juan Fortea

Get full text

Principales conclusiones acordadas durante la cumbre sobre discapacidad intelectual y demencia by Matthew P. JANICKI, Karen WATCHMAN, Juan FORTEA ORMAECHEA

Get full text

Cerebrospinal fluid biomarkers for Alzheimer's disease in Down syndrome by Alain D. Dekker, Juan Fortea, Rafael Blesa, Peter P. De Deyn

Get full text

Burnout among neurologists caring for patients with cognitive disorders in Spain by Juan Fortea, Elena García-Arcelay, Guillermo Garcia-Ribas, Neus Canal, Jorge Maurino

Get full text

Burnout among neurologists caring for patients with cognitive disorders in Spain. by Juan Fortea, Elena García-Arcelay, Guillermo Garcia-Ribas, Neus Canal, Jorge Maurino

Get full text

Raising awareness and addressing inequities for people with Down syndrome in South Africa by Eimear McGlinchey, Juan Fortea, Bulela Vava, Yvette Andrews, Kirti Ranchod, Atholl Kleinhans

Get full text

Feasibility and Long-Term Compliance to Continuous Positive Airway Pressure Treatment in Adults With Down Syndrome, a Genetic Form of Alzheimer’s Disease by Sandra Giménez, Ariadna Farre, Fátima Morente, Laura Videla, Laura Videla, Laura Videla, Marta Gutiérrez, Susana Clos, Ana Fernández, Marta Blanco, Miren Altuna, Miren Altuna, Jordi Pegueroles, Amparo Asensio, Bessy Benejam, Bessy Benejam, Bessy Benejam, Mar Batista, Isabel Barroeta, Isabel Barroeta, Ana Fortuna, Juan Fortea, Juan Fortea, Juan Fortea, Mercedes Mayos, Mercedes Mayos

Get full text

Atypical Creutzfeldt-Jakob Disease Evolution after Electroconvulsive Therapy for Catatonic Depression by Iria Grande, Juan Fortea, Ellen Gelpi, Itziar Flamarique, Marc Udina, Jordi Blanch, Raquel Sánchez-Valle

Get full text

Clinical and research application of fluid biomarkers in autosomal dominant Alzheimer's disease and Down syndrome by María Carmona-Iragui, Antoinette O'Connor, Jorge Llibre-Guerra, Patrick Lao, Nicholas J. Ashton, Juan Fortea, Raquel Sánchez-Valle

Get full text

Evaluation of cerebrospinal fluid levels of synaptic vesicle protein, VAMP-2, across the sporadic Alzheimer’s disease continuum by Julie Goossens, Alba Cervantes González, Nele Dewit, Laia Lidón, Juan Fortea, Daniel Alcolea, Alberto Lleó, Olivia Belbin, Eugeen Vanmechelen

Get full text

Prevalence of treated patients with Alzheimer’s disease: current trends and COVID-19 impact by Javier Olazarán, Cristóbal Carnero-Pardo, Juan Fortea, Pascual Sánchez-Juan, Guillermo García-Ribas, Félix Viñuela, Pablo Martínez-Lage, Mercè Boada

Get full text

YKL-40 (Chitinase 3-like I) is expressed in a subset of astrocytes in Alzheimer’s disease and other tauopathies by Marta Querol-Vilaseca, Martí Colom-Cadena, Jordi Pegueroles, Carla San Martín-Paniello, Jordi Clarimon, Olivia Belbin, Juan Fortea, Alberto Lleó

Get full text

DYRK1A and Activity-Dependent Neuroprotective Protein Comparative Diagnosis Interest in Cerebrospinal Fluid and Plasma in the Context of Alzheimer-Related Cognitive Impairment in D... by Manon Moreau, Maria Carmona-Iragui, Miren Altuna, Lorraine Dalzon, Isabel Barroeta, Marie Vilaire, Sophie Durand, Juan Fortea, Anne-Sophie Rebillat, Nathalie Janel

Get full text

Insights into the use of biomarkers in clinical trials in Alzheimer's disease by Tharick A. Pascoal, Cristiano S. Aguzzoli, Firoza Z. Lussier, Lucía Crivelli, Claudia K. Suemoto, Juan Fortea, Pedro Rosa-Neto, Eduardo R. Zimmer, Pamela C.L. Ferreira, Bruna Bellaver

Get full text

C-terminal fragments of the amyloid precursor protein in cerebrospinal fluid as potential biomarkers for Alzheimer disease by María-Salud García-Ayllón, Inmaculada Lopez-Font, Claudia P. Boix, Juan Fortea, Raquel Sánchez-Valle, Alberto Lleó, José-Luis Molinuevo, Henrik Zetterberg, Kaj Blennow, Javier Sáez-Valero

Get full text

Assessing general cognitive and adaptive abilities in adults with Down syndrome: a systematic review by Sarah Hamburg, Bryony Lowe, Carla Marie Startin, Concepcion Padilla, Antonia Coppus, Wayne Silverman, Juan Fortea, Shahid Zaman, Elizabeth Head, Benjamin L. Handen, Ira Lott, Weihong Song, André Strydom

Get full text

Accelerated long‐term forgetting over three months in asymptomatic APOE ɛ4 carriers by Adrià Tort‐Merino, Matti Laine, Natalia Valech, Jaume Olives, María León, Mirian Ecay‐Torres, Ainara Estanga, Pablo Martínez‐Lage, Juan Fortea, Raquel Sánchez‐Valle, Lorena Rami, Antoni Rodríguez‐Fornells

Get full text

Conducting clinical trials in persons with Down syndrome: summary from the NIH INCLUDE Down syndrome clinical trials readiness working group by Nicole T. Baumer, Mara L. Becker, George T. Capone, Kathleen Egan, Juan Fortea, Benjamin L. Handen, Elizabeth Head, James E. Hendrix, Ruth Y. Litovsky, Andre Strydom, Ignacio E. Tapia, Michael S. Rafii

Get full text

Apolipoprotein E imbalance in the cerebrospinal fluid of Alzheimer’s disease patients by Matthew Paul Lennol, Irene Sánchez-Domínguez, Inmaculada Cuchillo-Ibañez, Elena Camporesi, Gunnar Brinkmalm, Daniel Alcolea, Juan Fortea, Alberto Lleó, Guadalupe Soria, Fernando Aguado, Henrik Zetterberg, Kaj Blennow, Javier Sáez-Valero

Get full text